Echo-based screening of rheumatic heart disease in children: A cost-effectiveness Markov model

Journal of Medical Economics

Volumn 18, Issue 6, 2015, Pages 410-419

  Zachariah, Justin P ^a,b   Samnaliev, Mihail ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cost benefit analysis; Echocardiography; Pediatrics; Rheumatic heart disease; Valves

Indexed keywords

PENICILLIN DERIVATIVE; ANTIINFECTIVE AGENT; BENZATHINE PENICILLIN;

ADOLESCENT; ADULT; ARTICLE; CARDIOLOGIST; CHILD; COST EFFECTIVENESS ANALYSIS; ECHOCARDIOGRAPHY; ECONOMIC ASPECT; FOLLOW UP; HIDDEN MARKOV MODEL; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; PREVALENCE; QUALITY ADJUSTED LIFE YEAR; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SENSITIVITY ANALYSIS; ANTIBIOTIC PROPHYLAXIS; COST BENEFIT ANALYSIS; ECONOMICS; EPIDEMIOLOGY; HEART VALVE PROSTHESIS; MARKOV CHAIN; NORTHERN TERRITORY; PROCEDURES; RECURRENT DISEASE; STATISTICAL MODEL;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CHILD; COST-BENEFIT ANALYSIS; ECHOCARDIOGRAPHY; HEART VALVE PROSTHESIS; HUMANS; MARKOV CHAINS; MASS SCREENING; MODELS, ECONOMETRIC; NORTHERN TERRITORY; PENICILLIN G BENZATHINE; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; RECURRENCE; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE;

EID: 84935857365     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2015.1006366     Document Type: Article

References (53)

1. Marijon E, Mirabel M, Celermajer DS, et al. Rheumatic heart disease. Lancet 2012;379:953-64
2. Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group a streptococcal diseases. Lancet Infect Dis 2005;5:685-94
3. Manji RA, Witt J, Tappia PS, et al. Cost-effectiveness analysis of rheumatic heart disease prevention strategies. Expert Rev Pharmacoecon Outcomes Res 2013;13:715-24
4. Nordet P, Lopez R, Duenas A, et al. Prevention and control of rheumatic fever and rheumatic heart disease: The cuban experience (1986-1996-2002). Cardiovasc J Afr 2008;19:135-40
5. Bach JF, Chalons S, Forier E, et al. 10-year educational programme aimed at rheumatic fever in two french caribbean islands. Lancet 1996; 347:644-8
6. Zhang W, Mondo C, Okello E, et al. Presenting features of newly diagnosed rheumatic heart disease patients in mulago hospital: a pilot study. Cardiovasc J Afr 2013;24:28-33
7. Beaton A, Okello E, Lwabi P, et al. Echocardiography screening for rheumatic heart disease in ugandan schoolchildren. Circulation 2012;125:3127-32
8. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007; 357:470-6
9. Reeves BM, Kado J, Brook M. High prevalence of rheumatic heart disease in fiji detected by echocardiography screening. J Paediatr Child Health 2011;47:473-8
10. Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med 2007;357:439-41
11. Saxena A, Ramakrishnan S, Roy A, et al. Prevalence and outcome of subclinical rheumatic heart disease in india: the rheumatic (rheumatic heart echo utilisation and monitoring actuarial trends in indian children) study. Heart 2011;97:2018-22
12. Bhaya M, Beniwal R, Panwar S, et al. Two years of follow-up validates the echocardiographic criteria for the diagnosis and screening of rheumatic heart disease in asymptomatic populations. Echocardiography 2011; 28:929-33
13. Webb RH, Wilson NJ, Lennon DR, et al. Optimising echocardiographic screening for rheumatic heart disease in new zealand: not all valve disease is rheumatic. Cardiol Young 2011;21:436-43
14. Remenyi B, Wilson N, Steer A, et al. World heart federation criteria for echocardiographic diagnosis of rheumatic heart disease-an evidence-based guideline. Nat Rev Cardiol 2012;9:297-309
15. Webb R, Wilson NJ, Lennon D. Rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007;357:2088; author reply 2088-9
16. Northern Territory Government of Australia. 2013. Consumer affairs fuel price watch. http://www.Consumeraffairs.Nt.Gov.Au/pages/nt-fuel-watch. Aspx. Accessed 2013. Casuarina Northern Territory, Australia
17. Australian Bureau of Statistics. 2007. 4710.0 - housing and infrastructure in aboriginal and torres strait islander communities. http://www.Abs. Gov.Au/ausstats/abs@Nsf/latestproducts/4710.0main%20features42006? Opendocument&tabnamesummary&prodno4710.0&issue2006&num &view. Accessed 2013. Canberra, Australia
18. National Information and Referral Service. 2013. 6401.0 - consumer price index, Australia. http://www.Abs.Gov.Au/ausstats/abs@Nsf/mf/6401.0. Accessed 2013. Canberra, Australia
19. Miller G, Randolph S, Forkner E, Smith B, Galbreath AD. Long-term costeffectiveness of disease management in systolic heart failure. Med Decis Making 2009;29:325-33
20. Shiroiwa T, Sung YK, Fukuda T, et al. International survey on willingness-topay (wtp) for one additional qaly gained: What is the threshold of cost effectiveness? Health Econ 2010;19:422-37
21. Roberts KV, Brown AD, Maguire GP, et al. Utility of auscultatory screening for detecting rheumatic heart disease in high-risk children in australias northern territory. Med J Aust 2013;199:196-9
22. Irlam JH, Mayosi BM, Engel ME, et al. A cost-effective strategy for primary prevention of acute rheumatic fever and rheumatic heart disease in children with pharyngitis. S Afr Med J 2013;103:894-5
23. Soudarssanane MB, Karthigeyan M, Mahalakshmy T, et al. Rheumatic fever and rheumatic heart disease: Primary prevention is the cost effective option. Indian J Pediatr 2007;74:567-70
24. Irlam J, Mayosi BM, Engel M, et al. Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in south african children with pharyngitis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes 2013;6:343-51
25. Grimaldi A, Ammirati E, Mirabel M, et al. Challenges of using ultrasounds for subclinical rheumatic heart disease screening. Int J Cardiol 2013;167:3061
26. Jones TD, Bland EF. Rheumatic fever and heart disease, completed 10-year observations on 1000 patients. Tr A Am Phys 1942;57:8-12
27. Grant RT. After histories for ten years of a thousand men suffering from heart disease. Heart 1933;16:275
28. Ash R. The first ten years of rheumatic infection in childhood. Am Heart J 1948;36:89-97
29. Thomas GT. Five-year follow-up on patients with rheumatic fever treated by bed rest, steroids, or salicylate. Br Med J 1961;1:1635-9
30. Tompkins DG, Boxerbaum B, Liebman J. Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 1972;45:543-51
31. Sanyal SK, Berry AM, Duggal S, et al. Sequelae of the initial attack of acute rheumatic fever in children from north india. A prospective 5-year follow-up study. Circulation 1982;65:375-9
32. Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The natural history of rheumatic fever and rheumatic heart disease. Ten-year report of a cooperative clinical trial of acth, cortisone, and aspirin. Circulation 1965;32:457-76
33. Feinstein AR, Wood HF, Spagnuolo M, et al. Rheumatic fever in children and adolescents. A long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. Vii. Cardiac changes and sequelae. Ann Intern Med 1964;60(Suppl 5):87-123
34. Majeed HA, Batnager S, Yousof AM, et al. Acute rheumatic fever and the evolution of rheumatic heart disease: a prospective 12 year follow-up report. J Clin Epidemiol 1992;45:871-5
35. Bland EF, Duckett Jones T. Rheumatic fever and rheumatic heart disease; a twenty year report on 1000 patients followed since childhood. Circulation 1951;4:836-43
36. Carapetis JR, Powers JR, Currie BJ, et al. Outcomes of cardiac valve replacement for rheumatic heart disease in aboriginal australians. Asia Pacific Heart J 1999;8:138-47
37. Grover A, Dhawan A, Iyengar SD, et al. Epidemiology of rheumatic fever and rheumatic heart disease in a rural community in northern india. Bull World Health Organ 1993;71:59-66
38. International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. International rheumatic fever study group. Lancet 1991;337:1308-10
39. Carapetis JR, Currie BJ, Mathews JD. Cumulative incidence of rheumatic fever in an endemic region: A guide to the susceptibility of the population? Epidemiol Infect 2000;124:239-44
40. Carapetis JR, Currie BJ. Mortality due to acute rheumatic fever and rheumatic heart disease in the northern territory: a preventable cause of death in aboriginal people. Aust N Z J Public Health. 1999;23:159-63
41. Australian Bureau of Statistics. 2010. 3302 table 2: death rates, summary, states and territories-2002 to 2012. http://www.Abs.Gov.Au/ausstats/abs@ Nsf/detailspage/3302.02012?Opendocument. Accessed 2013. Canberra, Australia
42. Northern Territory Government: 2013. Department of health. Nursing salary structure. http://www.Nursing.Nt.Gov.Au/information/career-structuresalary. Accessed 2013. Casuarina, NT
43. Australian Institute of Ultrasound. 2013. Echocardiography fast track training. http://www.Aiu.Edu.Au/echocardiographyfasttrack.Php. Accessed 2013. Broadbeach Waters, Australia
44. Northern Territory Public Sector. Medical officers ntps enterprise agreement 2011-2013. 2013. http://www.Ocpe.Nt.Gov.Au/-data/assets/pdf-file/0019/53380/mo-2010-2013-ea.Pdf. Accessed 2013. Casuarina Northern Territory, Australia
45. Kam JK, Cooray SD, Smith JA, et al. A cost-analysis study of robotic versus conventional mitral valve repair. Heart Lung Circ 2010;19:413-18
46. Australian Bureau of Statistics. 5673.0.55.003 - regional wage and salary earner statistics, Australia. http://www.Abs.Gov.Au/ausstats/abs@Nsf/lookup/5673.0.55.003mainfeatures12005-06?Opendocument#paralink2. Accessed 2013. Canberra, Australia
47. Australia GPR. 2013. General practice registrars australia: salary structure. http://www.Gpra.Org.Au/benchmarking-survey. Accessed 2012. Melbourne, Australia
48. Australian Government Department of Health. 2012. Pencillin. http://www. Pbs.Gov.Au/medicine/item/1775k-3398w-3486l. Accessed 2013. Melbourne, Australia
49. Australian Government Department of Health. 2013. Lignocaine. http://www.Pbs.Gov.Au/medicine/item/2875h-3474w-5142p. Accessed 2013. Canberra, Australia
50. Australian Government Department Of Health. 2013. Enalapril. 2013. http://www.Pbs.Gov.Au/medicine/item/1369c. Accessed 2013. Canberra, Australia
51. Australian Government Department of Health. 2013. Frusemide. http://www.Pbs.Gov.Au/medicine/item/2412y. Accessed 2013. Canberra, Australia
52. Australian Government Department of Health. 2013. Coumarin. http://www.Pbs.Gov.Au/medicine/item/2211j. Accessed 2013. Canberra, Australia
53. Chambers S, Chadda S, Plumb JM. How much does international normalized ratio monitoring cost during oral anticoagulation with a vitamin k antagonist? A systematic review. Int J Lab Hematol 2010;32:427-42